COPD

September 19, 2014November 11, 2015

Drug-Free Mucus Clearance COPD Therapy Shows Positive Results

COPD, News

A recent study conducted by Trudell Medical International (TMI) demonstrated the effectiveness of the company’s Aerobika OPEP medical device in the treatment of Chronic Obstructive Pulmonary Disease (COPD), a condition that affects about 250 million ... Read more

September 18, 2014November 11, 2015

CHEST Foundation Offers Spanish COPD Materials Online

COPD, News

The U.S. is home to a wide variety of ethnicities and cultural backgrounds. In the field of scientific and medical research and development, there is a great unmet need for ... Read more

September 15, 2014November 11, 2015

Wearable, Comfortable COPD Breathing Device Gets Key Endorsements

COPD, News

California-based Breathe Technologies was recently granted CE Certification for its Non-Invasive Open Ventilation (NIOV) System, a medical technology for patients with respiratory insufficiency diseases and neuromuscular diseases, which will allow the company to market ... Read more

September 11, 2014November 11, 2015

Childhood Obesity May Precipitate Asthma

Asthma, COPD, News

The prevalence of obesity and asthma in children has been growing at an alarming rate. While these two conditions are pressing enough on their own, years of scientific observation and ... Read more

September 11, 2014November 11, 2015

New Data From GSK Shows Promising Blood Eosinophil Levels For Informing COPD Treatment Decisions

COPD, News

A team of GSK researchers recently presented at the European Respiratory Society (ERS) Congress data showing eosinophil levels in the blood may be predictors of exacerbation rates in patients with Chronic ... Read more

September 9, 2014November 11, 2015

Novartis Claims Once-Daily Ultibro Breezhaler Beats Seretide in Reducing COPD Flare-ups

COPD, News

For the first time, Novartis presented recent results showing a once-a-day Ultibro® Breezhaler® reduces disease exacerbations, i.e. an increase in disease severity, and improves lung function in patients with moderate-to-severe ... Read more

September 5, 2014November 11, 2015

Nearly Half of Studied COPD Patients Suffer Breathlessness

COPD, News

Shortness of breath, otherwise known as dyspnoea or “air hunger,” is a common symptom of chronic obstructive pulmonary disease (COPD). It is a serious problem that should not be ignored, ... Read more

September 2, 2014November 11, 2015

Data on Boehringer Ingelheim’s COPD, Asthma & IPF Therapies to Be Presented At Upcoming Conference

Asthma, COPD, News

According to the American Lung Association, more than 33 million people suffer from chronic lung disease, with Asthma and Chronic Obstructive Pulmonary Disease (COPD) being the most common conditions. Boehringer Ingelheim has a ... Read more

August 28, 2014November 11, 2015

Pharmaxis Ready to Start Test COPD and NASH Treatment on Humans

COPD, News

The chronic respiratory disorders pharmaceutical specialist Pharmaxis completed the development of its experimental drug, the Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein-1 (SSAO/VAP-1) Inhibitor (PXS4728A), which is designed to treat several forms of chronic inflammation ... Read more

August 20, 2014November 11, 2015

Tiotropium Respimat Recommended for FDA Approval to Treat COPD

COPD, News

In a 10-to-3 vote by the Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee (FDA PADAC), Boehringer Ingelheim Pharmaceuticals, Inc.’s investigational nasal spray tiotropium bromide has been recommended for approval ... Read more